Intravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model

ABSTRACT:

SUBMITTER: Venkataraman L 

PROVIDER: S-EPMC12396322 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature